Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
HCW Biologics ( (HCWB) ) has issued an announcement.
HCW Biologics Inc. has entered a $6.9 million securities purchase agreement with an institutional investor, involving a registered direct offering and a concurrent private placement of common stock and warrants. The offering, priced above market under NASDAQ rules, is expected to close shortly. The company is focused on developing innovative immunotherapies targeting inflammation and age-related diseases, and has secured a licensing deal for its preclinical candidate with WY Biotech, promising milestone payments and royalties.
See more insights into HCWB stock on TipRanks’ Stock Analysis page.
